About IEC

Aoxue Wang

Title: Vice director of Department of
Email: wangaxdl@163.com
Major: Dermatology

Education/Professional Experience

2007/09-2010/07,Dalian Medical University,Clinic of combination of Traditional Chinese and Western Medicine ,Doctor degree

2000/09-2003/07,Dalian Medical University,Dermatology,Master degree

1991/09-1996/07, Dalian Medical University,clinical medicine,Bachelor 

2012/09-2013/09, Karolinska Institutet, Sweden. visiting researcher

2012/11-now,The Second Hospital of Dalian Medical University, Department of Dermatology,Professor

2007/08-2012/10, The Second Hospital of Dalian Medical University, Department of Dermatology,Doctor-in-charge

2001/08-2007/07,The Second Hospital of Dalian Medical University, Department of Dermatology, Resident Doctor

Participation in the Academic Community

1、Committee of immune group of Dermatovenerologybranch ofChinese Medical Association,

2、Committee of allergic reaction branch ofChinese Association of the Integration of Traditional and Western Medicine,

3、 Committee of immune group ofLiaoning province.

Publication

1. Wang AX*, Landén N X. New insights into CD4+ T cells and their signature cytokines in atopic dermatitis. IUBMB Life. 2015 Aug;67(8):601-610.  (*Corresponding author)  (IF 3.143) 

2. Zhang YY#, Wang AX#,Xu L,Shen N, Zhu J, Tu CX. Characteristics of peripheral blood CD4+CD25+ regulatory T cells and related cytokines in severe atopic dermatitis. Eur J Dermatol. [accepted] (# Equally contribution) (IF:2.526)

3. Li D#, Wang A#, Liu X, Meisgen F, Grünler J, Botusan IR, Narayanan S, Erikci E, Li X, Blomqvist L, Du L, Pivarcsi A, Sonkoly E, Chowdhury K, Catrina SB,Ståhle M, Landén NX. MicroRNA-132 enhances transition from inflammation to proliferation during wound healing. J Clin Invest. 2015;125(8):3008-26.  (# Equally contribution) (IF: 13.8)

4. Wang A, Landén NX, Meisgen F, Lohcharoenkal W, Ståhle M, Sonkoly E, Pivarcsi A. MicroRNA-31 Is Overexpressed in Cutaneous Squamous Cell Carcinoma and Regulates Cell Motility and Colony Formation Ability of Tumor Cells. PLoS One. 2014;9(7):e103206. (IF 3.732)

5. Wang AX*, Qi XY.Targeting RAS/RAF/MEK/ERK signaling in metastatic melanoma. IUBMB Life. 2013;65(9):748-58. (*Corresponding author)  (IF 3.143)

6. Wang AX, Hu Y, Liu HX, Qi XY, Liu Y, Tu CX, Yang L. C5-hydroxylation of liquiritigenin is catalyzed selectively by CYP1A2. Xenobiotica. 2011 ;41(5):349-357.(IF1.791 )

7. Wang AX, Ge GB, Qi XY, Hu Y, Liang SC, Yang L, Tu CX. Rapid profiling and target analysis of principal components in Fuling Decoctions by UFLC-DAD-ESI-MS, Fitoterapia 2010;81(6):662-667. (IF 1.899)

Research Projects/Grants

1、2016-2017,Natural Science Foundation of China, “Development of microRNA-based therapy for chronic wounds” (81611130075)

2、2014-2016,Natural Science Foundation of China, “investigation ofthe molecular mechanism of peaoniflorin treatment of atopic dermatitis and its effect on microRNA expression” (81301365)

3、2014 07 -2017 06,Natural Science fund of Liaoning Province,(2014023011)                              

4、2012 01-2013 12,Fund of Dalian(2012E 15SF156)

Admission Plan/Requirements

1 person/ year

To be honest, hard-Working and optimistic.